Literature DB >> 3321083

Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.

M Okuni1, K Harada, H Yamaguchi, H Yanagawa, T Sonobe, T Kawasaki.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3321083

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  4 in total

1.  Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.

Authors:  H Suzuki; S Uemura; S Tone; T Iizuka; M Koike; K Hirayama; J Maeda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 2.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

Review 4.  Intravenous immunoglobulin for the treatment of Kawasaki disease in children.

Authors:  R M Oates-Whitehead; J H Baumer; L Haines; S Love; I K Maconochie; A Gupta; K Roman; J S Dua; I Flynn
Journal:  Cochrane Database Syst Rev       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.